Contact information
hooman.soleymanimajd@msd.ox.ac.uk
Ms Zoe Risk
office@gynaecologycareoxford.co.uk
http://www.gynaecologycareoxford.co.uk
https://orcid.org/0000-0003-3293-5321
He/Him
Biography
Mr. Hooman Soleymani majd is a highly skilled consultant in gynaecological oncology at the Churchill cancer centre in Oxford, a position he has held since 2017. He began his obstetrics and gynaecology career in London and completed his structured postgraduate training in Oxford, obtaining a certificate of completion of training and membership in the Royal College of Obstetricians and Gynaecologists. He further honed his expertise with three years of sub-specialty training in gynaecological oncology at the Churchill cancer centre.
A BSCCP-accredited colposcopist and trainer, Mr. Soleymani Majd is a member of the British Gynaecological Cancer Society (BGCS), International Society for Placenta Accreta Spectrum (IS-PAS) and the European Society of Gynaecological Oncology (ESGO). He is an accomplished surgeon, with particular expertise in ultra-radical surgery for advanced ovarian cancer, including upper abdominal surgery, liver mobilisation, and diaphragmatic reconstruction. He also has a dedicated interest in the surgical management of Placenta Accreta Spectrum (PAS) and is a founding member of the OxPAT group. Additionally, Mr. Soleymani majd is a member of the Oxford complex pelvic surgery (exenterative surgery) and sarcoma team. Beyond his clinical expertise, Mr. Soleymani majd is deeply committed to medical education, mentoring registrars, fellows and students at Oxford University. He is involved in research on advanced surgical techniques for ovarian cancer, with multiple publications on the subject in leading journals. He has also recently commissioned a special series of high impact articles on “Evolutions in the management of advanced ovarian cancer” for the Gynaecology and Pelvic Medicine journal.
He has a number of past and on-going collaborations with acclaimed researchers in the United Kingdom and abroad. He has authored book chapters and published prolifically in high impact peer-reviewed journal through the years. He is the co-editor for a new Oxford Surgical Handbook, which is currently being written and due to be published by Oxford University Press in due course. An invited speaker at numerous international congresses and webinars, he serves on the editorial boards of four international journals and has recently been appointed associate Editor-in-Chief of Translational Cancer Research (TCR).
Mr. Soleymani majd holds a Visiting Professorship at both Guangxi Medical University Cancer Hospital and Guangxi Medical University in Nanning, China. He is also a Visiting Professor in Chengdu, Sichuan University. In addition to his NHS work, he sees private patients at Nuffield Health, the Manor Hospital and between 2021 and 2025, he was awarded the iWantGreatCare certificate of excellence for outstanding patient care. Mr. Soleymani majd is passionate about teaching, research and committed to delivering the highest standards of patient care.
Hooman Soleymani majd
MD, MRCOG
Honorary Senior Clinical Lecturer
- Consultant Obstetrician & Gynaecologist
- Sub-specialist in Gynaecological Oncology Surgery
Oxford Collaborators
International Collaborators
Green Surgery Collaborative
COVIDSurg Collaborative
STARSurg Collaborative
Professor Federico Ferrari : University of Brescia, Italy
Professor Sarosh Irani : Mayo Clinic, Florida, USA
Key publications
Choosing the abdominal incision for the surgical management of severe placenta accreta spectrum: Patient satisfaction and long-term safety of the Soleymani and Collins transverse abdominal incision.
Journal article
Soleymani Majd H. et al, (2025), Int J Gynaecol Obstet, 169, 829 - 831
The Soleymani and Collins Obstetric morbidity score (SaCOMS): A quantitative tool for measuring maternal morbidity from complex obstetric surgery such as placenta accreta spectrum (PAS).
Journal article
Soleymani Majd H. et al, (2024), Eur J Obstet Gynecol Reprod Biol, 299, 148 - 155
Elective surgical services need to start planning for summer pressures.
Journal article
GreenSurg Collaborative ., (2023), Br J Surg, 110, 508 - 510
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.
Journal article
Hu Z. et al, (2020), Cancer Cell, 37, 226 - 242.e7
Recent publications
ificial intelligence as a diagnostic support tool in hysteroscopy: current evidence and clinical implications.
Journal article
Ferrari FA. et al, (2026), Minim Invasive Ther Allied Technol, 1 - 9
Placenta accreta spectrum and uterine SCAR dehiscence: Distinct entities or a continuum? An expert debate and call for standardization.
Journal article
Adu-Bredu T. et al, (2026), Acta Obstet Gynecol Scand
cute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report
Journal article
More AK. et al, (2026), Clinical Case Reports, 14
Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort study.
Journal article
Conforti J. et al, (2026), Transl Cancer Res, 15
The Application of Stepwise Pelvic Devascularisation in the Management of Severe Placenta Accreta Spectrum as Part of the Soleymani and Collins Technique for Caesarean Hysterectomy: Surgical Description and Evaluation of Short- and Long-Term Outcomes.
Journal article
Soleymani Majd H. et al, (2025), Diseases, 13
Insights from the Pre-Molecular Era in Advanced Endometrial Cancer: Benchmarking Prognostic Indicators in High-Risk Tumours.
Journal article
Conforti J. et al, (2025), J Clin Med, 14
Early non-compliance to ERAS in gynecological open surgery for malignancies, and post-operative complications: a multicenter, prospective, observational, cohort study.
Journal article
Ferrari F. et al, (2025), Int J Gynecol Cancer, 35